Archives of Gynecology and Obstetrics

, Volume 251, Issue 4, pp 181–185 | Cite as

The effect of periconceptional multivitamin-mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy

  • A. E. Czeizel
  • I. Dudas
  • G. Fritz
  • A. Técsöi
  • A. Hanck
  • G. Kunovits
Originals

Summary

Evidence is presented that periconceptional multivitamin-mineral supplementation can help to reduce nausea, vomiting and vertigo in early pregnancy.

Key words

Periconceptional multivitamin supplementation Nausea and vomiting 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Committee on Dietary Allowances (1980) Food and Nutrition Board, Recommended Dietary Allowances, Ninth revised Edition, National Academy of Sciences, Washington, D.C.Google Scholar
  2. Czeizel A (1988a) Medical genetics in Hungary. J Med Genet 25:2–8PubMedCrossRefGoogle Scholar
  3. Czeizel A (1988b) Neural tube defects. JAMA 259:3562PubMedCrossRefGoogle Scholar
  4. Czeizel A, Rodé K (1984) Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet II:40CrossRefGoogle Scholar
  5. Gant H, Reinken L, Dapunt O, Scholz K (1975) Vitamin B6 depletion in women with hyperemesis gravidarum. W Klin Wochenschr 87:510–517Google Scholar
  6. MRC Vitamin Study Research Group (1991) Prevention of neural tube defects: results of the medical research council vitamin study. Lancet 338:131–137CrossRefGoogle Scholar
  7. Smithells RW, Sheppard S, Schorah CJ, Seller MJ (1980) Possible prevention of neural tube defects by periconceptional vitamin supplementation. Lancet I:339–340CrossRefGoogle Scholar
  8. Smithells RW, Sheppard S, Wild J, Schorach CJ (1989) Prevention of neural tube defect recurrences in Yorkshire. Final report. Lancet II:498–499CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • A. E. Czeizel
    • 1
    • 2
  • I. Dudas
    • 1
    • 2
  • G. Fritz
    • 1
    • 2
  • A. Técsöi
    • 1
    • 2
  • A. Hanck
    • 1
    • 2
  • G. Kunovits
    • 1
    • 2
  1. 1.Department of Human Genetics and TeratologyNIH and WHO Collaborating Centre for the Community Control of Hereditary DiseasesBudapestHungary
  2. 2.F. Hoffmann-La Roche Ltd.BaselSwitzerland
  3. 3.OKIBudapestHungary

Personalised recommendations